TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 161 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $263,000 | +29.6% | 3,475 | +46.3% | 0.00% | +50.0% |
| Q2 2019 | $203,000 | -5.1% | 2,375 | +20.3% | 0.00% | 0.0% |
| Q1 2019 | $214,000 | +151.8% | 1,975 | +97.5% | 0.00% | +100.0% |
| Q4 2018 | $85,000 | -13.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $98,000 | -15.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $116,000 | -55.2% | 1,000 | -56.5% | 0.00% | -50.0% |
| Q3 2017 | $259,000 | +44.7% | 2,300 | +43.8% | 0.00% | 0.0% |
| Q2 2017 | $179,000 | -4.3% | 1,600 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $187,000 | +11.3% | 1,600 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $168,000 | +281.8% | 1,600 | +300.0% | 0.00% | – |
| Q3 2016 | $44,000 | -81.1% | 400 | -75.0% | 0.00% | -100.0% |
| Q2 2016 | $233,000 | +28.0% | 1,600 | +35.9% | 0.00% | 0.0% |
| Q4 2015 | $182,000 | – | 1,177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
| Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
| Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
| Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
| Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
| Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
| Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
| Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
| Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
| Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |